193 related articles for article (PubMed ID: 31308028)
1. Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer.
Chen C; Liu X; Chen C; Chen Q; Dong Y; Hou B
Ann Clin Lab Sci; 2019 May; 49(3):302-308. PubMed ID: 31308028
[TBL] [Abstract][Full Text] [Related]
2. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
[TBL] [Abstract][Full Text] [Related]
3. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
4. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
[TBL] [Abstract][Full Text] [Related]
5. Positive regulation of innate immune response by miRNA-let-7a-5p.
Ueta M; Nishigaki H; Komai S; Mizushima K; Tamagawa-Mineoka R; Naito Y; Katoh N; Sotozono C; Kinoshita S
Front Genet; 2022; 13():1025539. PubMed ID: 36685889
[No Abstract] [Full Text] [Related]
6. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
7. The transcardiac gradient of cardio-microRNAs in the failing heart.
Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM
Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer.
Marques MM; Evangelista AF; Macedo T; Vieira RADC; Scapulatempo-Neto C; Reis RM; Carvalho AL; Silva IDCGD
Clinics (Sao Paulo); 2018 Jul; 73():e184. PubMed ID: 29995098
[TBL] [Abstract][Full Text] [Related]
9. MiR-10a, miR-15a, let-7a, and let-7g expression as stress-relevant biomarkers to assess acute or chronic psychological stress and mental health in human capillary blood.
Krammer UDB; Lerch ML; Haslberger AG; Hippe B
Mol Biol Rep; 2023 Jul; 50(7):5647-5654. PubMed ID: 37193801
[TBL] [Abstract][Full Text] [Related]
10. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
11. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
13. Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs.
Barbagallo C; Passanisi R; Mirabella F; Cirnigliaro M; Costanzo A; Lauretta G; Barbagallo D; Bianchi C; Pagni F; Castorina S; Granata A; Di Pietro C; Ragusa M; Malatino LS; Purrello M
J Cell Physiol; 2019 Aug; 234(8):12625-12636. PubMed ID: 30515781
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
[TBL] [Abstract][Full Text] [Related]
15. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
16. Identification of Epigenetic Interactions between miRNA and Gene Expression as Potential Prognostic Markers in Bladder Cancer.
Awadalla A; Abol-Enein H; Hamam ET; Ahmed AE; Khirallah SM; El-Assmy A; Mostafa SA; Babalghith AO; Ali M; Abdel-Rahim M; Shokeir AA; Harraz AM
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140796
[TBL] [Abstract][Full Text] [Related]
17. Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.
Xu Q; Dong QG; Sun LP; He CY; Yuan Y
BMC Clin Pathol; 2013 Mar; 13():11. PubMed ID: 23521833
[TBL] [Abstract][Full Text] [Related]
18. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
